Loading patent…
OwnerGuillaume LEVILAIN, Tia JACOBS +5inventors
InventorsGuillaume LEVILAIN, Tia JACOBS, Britta OLENIK, Franco RUBINO, Krischan ZIEM, Michal SOWA, Susanne RÖHRIG
Estimating the term…
The present invention relates to crystalline forms of (4S)-24-chloro-4-ethyl-73-fluoro-35-methoxy-32,5-dioxo-14-(trifluoromethyl)-32H-6-aza-3(4,1)-pyridina-1(1)-[1,2,3]triazola-2(1,2),7(1)-dibenzenaheptaphane-74-carboxamide which are the crystalline modification I and the crystalline modification II, to processes for their preparation, to pharmaceutical compositions comprising them and to their use in the control of disorders.
A crystalline form of (4S)-24-chloro-4-ethyl-73-fluoro-35-methoxy-32,5-dioxo-14-trifluoromethyl)-32H-6-aza-3(4,1)-pyridina-1(1)-[1,2,3]triazola-2(1,2),7(1)-dibenzenaheptaphane-74-carboxamide having the following formula (I)
4-({(2S)-2-[4-{3-chloro-2-fluoro-6-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2H)-yl]propanoyl}amino)-2-fluorobenzamide having the formula (II)
Dependencies are inferred from the claim text.